Monograph Details
|
|
Pain & Pyrexia
> Narcotic analgesics
|
|
ORAMORPH SR |
| Manufacturer |
|
Xanodyne Pharmacal, Inc. |
| Legal Classification |
|
CII |
| Pharmacological Class |
|
Opioid. |
| Generic Name |
|
Morphine sulfate 15mg, 30mg, 60mg, 100mg; sust-rel tabs. |
| Indications |
|
Pain management when an opioid analgesic is appropriate for more than a few days. |
| Children |
|
Not recommended. |
| Adults |
|
Swallow whole. Individualize. See literature. |
| Contraindications |
|
Severe respiratory depression. Asthma. Paralytic ileus. |
| Precautions |
|
Head injury. Increased intracranial pressure. Acute abdomen. Shock. Impaired renal, hepatic, thyroid, pulmonary, or adrenocortical function. GI or GU obstruction. Biliary tract surgery. Kyphoscoliosis. Acute pancreatitis. Convulsive disorders. Delirium tremens. Drug abusers. Elderly. Debilitated. Pregnancy (Cat C.). Labor & delivery, nursing mothers: not recommended. |
| Interactions |
|
Potentiation with alcohol, CNS depressants. Do not use within 14 days of MAOIs. Severe hypotension with phenothiazines. |
| Adverse Reactions |
|
High abuse potential, sedation, drowsiness, GI upset, constipation, urinary retention, respiratory depression, orthostatic hypotension, syncope, dysphoria, euphoria. |
| How Supplied |
|
Tabs—100 |
|
|
|
|
